28942794 29957921 34952161 34663684 35873822 33924963 29321620 30670570 35599495 36085537 30048714 32625052 34495322 29246723 28202670 30045977 32410948 28041945 33706934 29680709 32498494 30363623 28289968 30858560 30927072 32247367 30837320 3250856 - Search Results

Year	Number of Results
2015	3
2016	19
2017	20
2018	24
2019	17
2020	29
2021	19
2022	22
2023	0

1

Mastrangelo L. Mastrangelo L. Adv Genet. 2017;98:43-62. doi: 10.1016/bs.adgen.2017.08.001. Epub 2017 Sep 2. Adv Genet. 2017. PMID: 28942794 Review.

2

Novel Targets for Parkinson's Disease: Addressing Different Therapeutic Paradigms and Conundrums.

Rane P, Sarmah D, Bhute S, Kaur H, Goswami A, Kalia K, Borah A, Dave KR, Sharma N, Bhattacharya P. Rane P, et al. ACS Chem Neurosci. 2019 Jan 16;10(1):44-57. doi: 10.1021/acschemneuro.8b00180. Epub 2018 Jul 11. ACS Chem Neurosci. 2019. PMID: 29957921 Review.

3

Animal models of brain-first and body-first Parkinson's disease.

Van Den Berge N, Ulusoy A. Van Den Berge N, et al. Neurobiol Dis. 2022 Feb;163:105599. doi: 10.1016/j.nbd.2021.105599. Epub 2021 Dec 22. Neurobiol Dis. 2022. PMID: 34952161 Free article. Review.

4

Parkinson Disease: Translating Insights from Molecular Mechanisms to Neuroprotection.

Pirooznia SK, Rosenthal LS, Dawson VL, Dawson TM. Pirooznia SK, et al. Pharmacol Rev. 2021 Oct;73(4):33-97. doi: 10.1124/pharmrev.120.000189. Pharmacol Rev. 2021. PMID: 34663684 Review.

5

G2019S LRRK2 Mutation Enhances MPP⁺-Induced Inflammation of Human Induced Pluripotent Stem Cells-Differentiated Dopaminergic Neurons.

Chen Y, Yin Q, Cheng XY, Zhang JR, Jin H, Li K, Mao CJ, Wang F, Bei HZ, Liu CF. Chen Y, et al. Front Neurosci. 2022 Jul 6;16:947927. doi: 10.3389/fnins.2022.947927. eCollection 2022. Front Neurosci. 2022. PMID: 35873822 Free PMC article.

6

Genes Implicated in Familial Parkinson's Disease Provide a Dual Picture of Nigral Dopaminergic Neurodegeneration with Mitochondria Taking Center Stage.

Franco R, Rivas-Santisteban R, Navarro G, Pinna A, Reyes-Resina I. Franco R, et al. Int J Mol Sci. 2021 Apr 28;22(9):4643. doi: 10.3390/ijms22094643. Int J Mol Sci. 2021. PMID: 33924963 Free PMC article. Review.

7

Lack of PINK1 alters glia innate immune responses and enhances inflammation-induced, nitric oxide-mediated neuron death.

Sun L, Shen R, Agnihotri SK, Chen Y, Huang Z, Büeler H. Sun L, et al. Sci Rep. 2018 Jan 10;8(1):383. doi: 10.1038/s41598-017-18786-w. Sci Rep. 2018. PMID: 29321620 Free PMC article.

8

Kinase activity of mutant LRRK2 manifests differently in hetero-dimeric vs. homo-dimeric complexes.

Leandrou E, Markidi E, Memou A, Melachroinou K, Greggio E, Rideout HJ. Leandrou E, et al. Biochem J. 2019 Feb 8;476(3):559-579. doi: 10.1042/BCJ20180589. Biochem J. 2019. PMID: 30670570

9

Evaluation of Current Methods to Detect Cellular Leucine-Rich Repeat Kinase 2 (LRRK2) Kinase Activity.

Fernández B, Chittoor-Vinod VG, Kluss JH, Kelly K, Bryant N, Nguyen APT, Bukhari SA, Smith N, Lara Ordóñez AJ, Fdez E, Chartier-Harlin MC, Montine TJ, Wilson MA, Moore DJ, West AB, Cookson MR, Nichols RJ, Hilfiker S. Fernández B, et al. J Parkinsons Dis. 2022;12(5):1423-1447. doi: 10.3233/JPD-213128. J Parkinsons Dis. 2022. PMID: 35599495 Free PMC article.

10

Lysosomal Pathogenesis of Parkinson's Disease: Insights From LRRK2 and GBA1 Rodent Models.

Volta M. Volta M. Neurotherapeutics. 2022 Sep 9. doi: 10.1007/s13311-022-01290-z. Online ahead of print. Neurotherapeutics. 2022. PMID: 36085537 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results